Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer

BACKGROUND: Consolidation durvalumab improved overall survival (OS) in locally advanced non-small cell lung cancer (LA-NSCLC) treated with chemoradiotherapy (CRT) in the PACIFIC trial; however, pneumonitis was increased with durvalumab. We sought to examine real-world outcomes with the PACIFIC parad...

詳細記述

保存先:
書誌詳細
出版年:J Thorac Dis
主要な著者: Hassanzadeh, Comron, Sita, Timothy, Savoor, Rohan, Samson, Pamela P., Bradley, Jeffrey, Gentile, Michelle, Roach, Michael, Mohindra, Nisha, Waqar, Saiama, Kruser, Timothy J., Robinson, Clifford
フォーマット: Artigo
言語:Inglês
出版事項: AME Publishing Company 2020
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7711405/
https://ncbi.nlm.nih.gov/pubmed/33282370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-20-1792
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料